The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents.
Leave a Comment
You must be logged in to post a comment.